@FiercePharma: Shanghai Pharma's ex-CEO gets suspended death sentence in bribery/graft case. If he behaves, he'll get life in prison. News | Follow @FiercePharma
> FDA inspectors cited Genentech for shortfalls at a San Francisco, CA, plant after 13 visits this year. Story
> Researchers stopped recruiting patients for a trial of Amgen's Vectibix in stomach and esophageal cancer after patients receiving the drug saw inferior outcomes. News
> The former CEO of state-owned Shanghai Pharmaceutical got a suspended death sentence in a corruption case that included charges of accepting bribes and embezzling public funds. Report
> Salix Pharmaceuticals agreed to buy Oceana Therapeutics for $300 million to get access to the latter's bowel-control and bladder drugs. Item
> Lundbeck's Q3 sales grew by 10% to 3.98 billion kronor ($729 million), despite 12% drop in Lexapro sales; antidepressant has generic rivals in three European countries. News
> Roche's experimental skin cancer drug vismodegib won priority review from the FDA as a treatment for patients with advanced basal cell carcinoma that can't be treated with surgery. Article
> Piper Jaffray analysts gave Vertex Pharmaceuticals a new, lower price target of $56, while Robert W. Baird downgraded shares to "neutral" and cut their price target to $33 from $62. Story
> Sinopharm plans to raise $1.5 billion to $2 billion from a Hong Kong IPO during the first half of 2012. More
Biotech News
@FierceBiotech: Alkermes keeps drug-delivery ties intact in Lilly-Amylin breakup. Article | Follow @FierceBiotech
@JohnCFierce: Startup Rhythm (Boston) gets Merck development vet Keith M. Gottesdiener as new CEO. Release | Follow @JohnCFierce
@RyanMFierce: Mylan is buying Pfizer's respiratory drug delivery tech. Release focus is on COPD. | Follow @RyanMFierce
@MaureenFierce: Chuck Norris (yes, Chuck Norris) is the newest anti-vaccine activist. Celebrities + science = fun! More | Follow @MaureenFierce
> Hot Ablynx antibody tech earns $69M discovery pact with Merck Serono. Story
> Fledgling Rhythm recruits Merck vet to helm the Boston biotech. Report
Medical Device News
> Pivot secures $32M in Series C. Piece
> FDA clears Cordis' Empira catheters. Item
Drug Delivery News
> Sunovion's inhaled steroid for allergies looks good in Ph3 amid FDA review. More
> Alkermes keeps drug-delivery ties intact in Lilly-Amylin breakup. Story
> Bioject axes 38% of staff as needle-free biz faces revenue, FDA hurdles. Article
> Neuroderm reportedly sees promising data for Parkinson's drug patch. Report
And Finally... Wal-Mart looks for partners for aggressive push into primary healthcare. News